Antidotes Market - Emergence of Innovations to Offer Rich Growth Opportunity | Boehringer Ingelheim, AstraZeneca, Novartis, Eli Lilly, Portola, Pfizer, Bristol-Myers Squibb, Baye

The latest research study released by Stratagem Market Insights with 100+ pages of analysis, This “Global Antidotes Market Insights Report 2020-2027“ highlights key market dynamics of the industry and covers historic data, current market trends, environment, technological innovation, upcoming technologies and the technical progress in the associated industry. Attaining complete info about the trends and opportunities in the industry is a fairly time-consuming process that is eased with this report. Top players in the market, major collaborations, mergers, and acquisitions alongside trending innovation and business policies are additionally re-evaluated in this market research report. What is more, the statistical facts included in this report are interpreted with the help of most established tools such as SWOT analysis and Porter’s Five Forces Analysis.

Get Exclusive Sample Copy of This Report Here: https://www.stratagemmarketinsights.com/sample/5878

Antidotes are chelating drugs that are used to neutralize the effect of poison or other drugs. Antidotes are widely used to neutralized cyanide poisoning, benzodiazepine poisoning, opioid poisoning, and other toxins. Pralidoxime, naloxone, flumazenil, and dimercaprol are some of the antidotes. Antidotes are also used to neutralize the poison caused by snakebite and poison caused by a chronic medical condition.

Growing cases of snakebite across the Asia Pacific region is predominantly fueling the market growth of the antidotes. Rising prevalence of various medical conditions associated with antidotes such as trichotillomania, smoking cessation, toxoplasmosis prophylaxis, and a reversal of sedation is also contributing to the market growth. Moreover, development in the infrastructure of the healthcare industry coupled with the increasing studies by manufacturer and researcher to study the effect of antidotes in order to develop novel antidotes is further expected to accelerate the market growth. According to the Charlton Media Group, Asia's overall healthcare spending is projected to surge to US$2.27t by 2026 from US$1.69t in 2017.

Moreover, growth in the pharmaceutical industry in the Asia Pacific region is also projected to foster the market growth of the antidotes. According to the India Brand Equity Foundation, the Indian pharmaceutical sector is projected to grow to US$ 100 billion, and the medical device market expected to grow US$ 25 billion by 2025. Moreover, pharmaceutical exports from India stood at US$ 19.14 billion in 2019 and US$ 13.69 billion in 2020. Furthermore, rise in the geriatric population coupled with the increasing cases of chronic disease in the region is further expected to propel the market growth of the antidotes. According to The United Nations Population Fund By 2050, one in four people in Asia and the Pacific will be over 60 years old. The population of older persons (aged over 60) in the region will triple between 2010 and 2050, reaching close to 1.3 billion people.

On the other hand, the high cost of anti-venoms is projected to restrict the market growth of the Asia Pacific antidotes.

Key Developments:

• In March 2020, Mumbai based API major, Lasa Supergenerics Ltd in partnership with the Institute of Chemical Technology (ICT) announced the commencement for the development of antiviral compound Favipiravir as Covid19 treatment. Favipiravir is an antiviral drug and is a promising antidote for the treatment of Coronavirus disease.

Market Players:

• Boehringer Ingelheim
• AstraZeneca
• Novartis
• Eli Lilly
• Portola
• Pfizer
• Bristol-Myers Squibb
• Baye

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
• Chemical Antidotes
• Physical Antidotes
• Pharmacological Antidotes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Antidote for each application, including
• Animal Bites
• Heavy Metal Poisoning
• Others

Buy now this report to grow your Business: https://www.stratagemmarketinsights.com/cart/5878

Key poles of the TOC:

Chapter 1 Global Antidotes Market Business Overview
Chapter 2 Major Breakdown by Type
Chapter 3 Major Application Wise Breakdown (Revenue & Volume)
Chapter 4 Manufacture Market Breakdown
Chapter 5 Sales & Estimates Market Study
Chapter 6 Key Manufacturers Production and Sales Market Comparison Breakdown
…………………..
Chapter 8 Manufacturers, Deals and Closings Market Evaluation & Aggressiveness
Chapter 9 Key Companies Breakdown by Overall Market Size & Revenue by Type
…………………....
Chapter 11 Business / Industry Chain (Value & Supply Chain Analysis)
Chapter 12 Conclusions & Appendix

[**NOTE: “Enquiry Before Buying” option enables you to share your queries, in advance to procure the report. Kindly fill the enquiry form, and one of our consultants would get in touch with you to discuss the queries and would address them.]

Else place an Inquire before Purchase “Global Antidotes Market Size, Share, Growth, and Forecast 2027” @ https://www.stratagemmarketinsights.com/quiry/5878

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe, or Asia.

Contact us:

Mr. Shah
Stratagem Market Insights
Tel: +1 415 871 0703
Email: sales@stratagemmarketinsights.com
For More Report @ S_Blogs

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.

This release was published on openPR.